These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26520417)

  • 1. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
    Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M
    Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
    Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
    Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
    Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
    Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
    Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC
    Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
    Tamaki S; Fukuta M; Sekiguchi K; Jin Y; Nagata S; Hayakawa K; Hineno S; Okamoto T; Watanabe M; Woltjen K; Ikeya M; Kato T; Toguchida J
    PLoS One; 2015; 10(11):e0142991. PubMed ID: 26571495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis.
    Lasota J; Chłopek M; Kaczorowski M; Natálie K; Ryś J; Kopczyński J; Sulaieva O; Michal M; Kruczak A; Harazin-Lechowska A; Szczepaniak M; Koshyk O; Hałoń A; Czapiewski P; Abdullaev Z; Kowalik A; Aldape KD; Michal M; Miettinen M
    Am J Surg Pathol; 2024 Jan; 48(1):97-105. PubMed ID: 37899499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma.
    Miura K; Shimizu K; Eguchi T; Koike S; Matsuoka S; Takeda T; Hamanaka K; Uehara T
    Diagn Pathol; 2021 Jun; 16(1):54. PubMed ID: 34127031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic synovial sarcoma of the pleura mimicking a cystic thymoma: a case report illustrating the role of decreased INI-1 expression in differential diagnosis.
    Tajima S; Takahashi T; Itaya T; Koda K; Neyatani H
    Int J Clin Exp Pathol; 2015; 8(3):3262-9. PubMed ID: 26045850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
    Rekhi B; Jambhekar NA
    Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
    Vergara-Lluri ME; Stohr BA; Puligandla B; Brenholz P; Horvai AE
    Am J Surg Pathol; 2012 Jul; 36(7):1093-8. PubMed ID: 22743288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel SSX1 fusions in synovial sarcoma.
    Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
    Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma.
    Mularz K; Harazin-Lechowska A; Ambicka A; Kruczak A; Rozmus-Piętoń M; Marchińska-Osika U; Swiątkiewicz I; Król M; Pabis D; Januś G; Ryś J
    Pol J Pathol; 2012 Nov; 63(3):179-83. PubMed ID: 23161234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.